Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
暂无分享,去创建一个
Minmin Shi | C. Peng | R. Zhao | B. Shen | Xi Cheng | Xiaoqian Jing | Huo Wu | Wei-hua Qiu | Ding Ma | Zhi-Jian Jin | Stanley Yuen
[1] Yufang Shi,et al. TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils , 2016, Oncogene.
[2] J. Zhao,et al. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis , 2017, Gastric Cancer.
[3] C. Yen,et al. ANGPTL1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma Cells , 2016 .
[4] W. Qiu,et al. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling , 2016, Oncotarget.
[5] S. Panda,et al. Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions. , 2016, Oral oncology.
[6] Yingying Zhang,et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/syndecan-1/TGF-β autocrine loop , 2016, Oncotarget.
[7] Z. Li,et al. Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a , 2016, Oncotarget.
[8] W. Qiu,et al. Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo. , 2016, Oncology reports.
[9] V. Thongboonkerd,et al. Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells , 2016, Scientific Reports.
[10] Sheng-Nan Lu,et al. Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival , 2016, Scientific Reports.
[11] W. Qiu,et al. Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. , 2016, Cancer research.
[12] Y. Zong,et al. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer , 2016, Oncotarget.
[13] W. Qiu,et al. GADD45β induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia , 2016, Oncotarget.
[14] Jun Yu,et al. CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation. , 2016, International journal of oncology.
[15] W. Qiu,et al. FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation , 2016, Medical Oncology.
[16] Kui Wang,et al. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. , 2016, JAMA surgery.
[17] Yinglong Zhang,et al. CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model , 2015, Scientific Reports.
[18] Keda Yu,et al. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse , 2015, Oncotarget.
[19] Bingya Liu,et al. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling. , 2015, Biochimica et biophysica acta.
[20] L. Du,et al. Aberrant CCR4 Expression Is Involved in Tumor Invasion of Lymph Node-Negative Human Gastric Cancer , 2015, PloS one.
[21] Lianyu Chen,et al. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases , 2014, Scientific Reports.
[22] C. Chen,et al. Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells , 2014, British Journal of Cancer.
[23] W. Qiu,et al. Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis , 2014, Medical Oncology.
[24] D. Xie,et al. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. , 2012, Cancer cell.
[25] G. Di,et al. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer , 2012, Breast Cancer Research and Treatment.
[26] S. Briest,et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. , 2009, Cancer research.
[27] J. Y. Lee,et al. The Chemokine Receptor CCR4 is Expressed and Associated With a Poor Prognosis in Patients With Gastric Cancer , 2009, Annals of surgery.
[28] J. Blay,et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.
[29] F. Schmidt. Meta-Analysis , 2008 .
[30] I-Chung Lo,et al. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. , 2005, Journal of biomedical science.
[31] Y. Yen,et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. , 2003, The American journal of pathology.
[32] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.